Clinical Trial Update: Validation of ClarityDX Prostate as a Reflex Test to Refine the Prediction of Clinically-significant Prostate Cancer

View source ↗

Summary

Nanostics reports validation of ClarityDX Prostate as a reflex diagnostic test to refine the prediction of clinically significant prostate cancer; the study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• ClarityDX Prostate

Snippet

Sponsor: Nanostics | Conditions: Prostate Cancer | Status: ACTIVE_NOT_RECRUITING